Deering, Kathleen L http://orcid.org/0000-0003-1438-444X
Larsen, Niccole J
Loustau, Patrick
Weiss, Blandine
Allas, Soraya
Culler, Michael D
Harshaw, Qing
Mitchell, Deborah M.
Funding for this research was provided by:
Amolyt Pharma (Amolyt Pharma)
Article History
Received: 19 September 2023
Accepted: 28 March 2024
First Online: 18 April 2024
Declarations
:
: As this was an analysis of existing medical and pharmacy claims and cost data, and no individually identifiable information were included in the data sets, institutional review board approval was not required.
: Not applicable.
: Not applicable.
: K.L.D. and Q.H. are employees of EPI-Q, Inc., which received payment from Amolyt Pharma, Cambridge, Massachusetts, USA, and Ecully, France, for the development and execution of this study. N.J.L., P.L., B.W., S.A., and M.D.C. are employees of Amolyt Pharma, Cambridge, Massachusetts, USA, and Ecully, France. D.M.M. was a scientific advisor on this study and received an honorarium from Amolyt Pharma.